Acrivon Therapeutics, Inc. Common Stock

NASDAQ:ACRV

Biotechnology

Healthcare
$1.40 +3.16%

+$0.05 today

Market cap
$60.08M
Beta
1.91
P/E (TTM)
-0.8
EPS (TTM)
-$2.00
52W Low $1.15High $3.56

Volume 0.37M

Average 0.60M

Price history

Acrivon Therapeutics, Inc. Common Stock SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-40.68%

Period high

$3.01

Period low

$1.29

Latest

$1.40

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 10, 2026Nov 10, 2026
8-KNov 6, 2026Nov 6, 2026
4Oct 26, 2026Oct 26, 2026
4Oct 7, 2026Oct 7, 2026
3Sep 2, 2026Sep 2, 2026
4Sep 2, 2026Sep 2, 2026
4Aug 27, 2026Aug 27, 2026
4Aug 20, 2026Aug 20, 2026
4Aug 20, 2026Aug 20, 2026
4Aug 20, 2026Aug 20, 2026
4Aug 20, 2026Aug 20, 2026
4Aug 20, 2026Aug 20, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
8-KAug 12, 2026Aug 12, 2026
S-8Aug 12, 2026Aug 12, 2026

Competitors

Who does Acrivon Therapeutics, Inc. Common Stock compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ACRV's filings, answered from its disclosures.

What is the latest ACRV filing?

The latest filing shown is 8-K dated Nov 10, 2026.

How many recent filings does ACRV have?

Intrinsic Alpha currently shows 20 recent filings for ACRV.